Estimands and their Estimators for Clinical Trials Impacted by the COVID-19 Pandemic: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions
The COVID-19 pandemic continues to affect the conduct of clinical trials globally. Complications may arise from pandemic-related operational challenges such as site closures, travel limitations and interruptions to the supply chain for the investigational product, or from health-related challenges s...
Saved in:
Published in | Statistics in biopharmaceutical research Vol. 15; no. 1; pp. 94 - 111 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Taylor & Francis
02.01.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!